Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Current Assets (2021 - 2026)

Longeveron (LGVN) posted quarterly Current Assets of $16.9 million for Q1 2026, up 10.34% year-over-year from $15.3 million in Q1 2025, and up 209.21% quarter-over-quarter from $5.5 million in Q4 2025.

Longeveron (LGVN) Current Assets (2021 - 2026) Analysis & Trends

Longeveron's Current Assets history runs 6 years deep, the most recent figure standing at $16.9 million for Q1 2026.

  • In Q1 2026, Current Assets rose 10.34% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $16.9 million (up 10.34% YoY), while the FY2025 annual figure was $5.5 million, down 72.22% from the prior year.
  • Current Assets for Q1 2026 stood at $16.9 million, up from $5.5 million in the prior quarter.
  • The five-year high for Current Assets was $23.8 million in Q3 2024, with the low at $3.8 million in Q1 2024.
  • The 5-year median for Current Assets is $12.3 million (2024), against an average of $12.6 million.
  • Peak annual rise in Current Assets reached 371.19% in 2024, while the deepest fall reached 74.73% in 2024.
  • Longeveron's Current Assets stood at $20.3 million in 2022, then slumped by 71.16% to $5.8 million in 2023, then surged by 235.57% to $19.6 million in 2024, then sank by 72.22% to $5.5 million in 2025, then surged by 209.21% to $16.9 million in 2026.
  • Business Quant data shows LGVN's Current Assets at $16.9 million in Q1 2026, $5.5 million in Q4 2025, and $10.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.82 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 7.22 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.62 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.63 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 1.76 Bn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 11.32 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 11.32 Mn
Mar 31, 2026 16.86 Mn
Dec 31, 2025 5.45 Mn
Sep 30, 2025 10.34 Mn
Jun 30, 2025 11.27 Mn
Mar 31, 2025 15.28 Mn
Dec 31, 2024 19.62 Mn
Sep 30, 2024 23.77 Mn
Jun 30, 2024 13.41 Mn
Mar 31, 2024 3.76 Mn
Dec 31, 2023 5.85 Mn
Sep 30, 2023 5.04 Mn
Jun 30, 2023 10.29 Mn
Mar 31, 2023 14.87 Mn
Dec 31, 2022 20.28 Mn
Dec 31, 2021 35.38 Mn